BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 18991627)

  • 1. CRM1-mediated nuclear export of proteins and drug resistance in cancer.
    Turner JG; Sullivan DM
    Curr Med Chem; 2008; 15(26):2648-55. PubMed ID: 18991627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear export of proteins and drug resistance in cancer.
    Turner JG; Dawson J; Sullivan DM
    Biochem Pharmacol; 2012 Apr; 83(8):1021-32. PubMed ID: 22209898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of CRM1-dependent nuclear export sensitizes malignant cells to cytotoxic and targeted agents.
    Turner JG; Dawson J; Cubitt CL; Baz R; Sullivan DM
    Semin Cancer Biol; 2014 Aug; 27():62-73. PubMed ID: 24631834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nucleo-cytoplasmic transport as a therapeutic target of cancer.
    Gravina GL; Senapedis W; McCauley D; Baloglu E; Shacham S; Festuccia C
    J Hematol Oncol; 2014 Dec; 7():85. PubMed ID: 25476752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CRM1/Ran-mediated nuclear export of p27(Kip1) involves a nuclear export signal and links p27 export and proteolysis.
    Connor MK; Kotchetkov R; Cariou S; Resch A; Lupetti R; Beniston RG; Melchior F; Hengst L; Slingerland JM
    Mol Biol Cell; 2003 Jan; 14(1):201-13. PubMed ID: 12529437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A cellular reporter to evaluate CRM1 nuclear export activity: functional analysis of the cancer-related mutant E571K.
    García-Santisteban I; Arregi I; Alonso-Mariño M; Urbaneja MA; Garcia-Vallejo JJ; Bañuelos S; Rodríguez JA
    Cell Mol Life Sci; 2016 Dec; 73(24):4685-4699. PubMed ID: 27312238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclear Export as a Novel Therapeutic Target: The CRM1 Connection.
    Lu C; Figueroa JA; Liu Z; Konala V; Aulakh A; Verma R; Cobos E; Chiriva-Internati M; Gao W
    Curr Cancer Drug Targets; 2015; 15(7):575-92. PubMed ID: 26324128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Importins and exportins as therapeutic targets in cancer.
    Mahipal A; Malafa M
    Pharmacol Ther; 2016 Aug; 164():135-43. PubMed ID: 27113410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for specific nucleocytoplasmic transport pathways used by leucine-rich nuclear export signals.
    Elfgang C; Rosorius O; Hofer L; Jaksche H; Hauber J; Bevec D
    Proc Natl Acad Sci U S A; 1999 May; 96(11):6229-34. PubMed ID: 10339570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A non-canonical mechanism for Crm1-export cargo complex assembly.
    Fischer U; Schäuble N; Schütz S; Altvater M; Chang Y; Faza MB; Panse VG
    Elife; 2015 Apr; 4():. PubMed ID: 25895666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterozygous mutation of cysteine528 in XPO1 is sufficient for resistance to selective inhibitors of nuclear export.
    Neggers JE; Vanstreels E; Baloglu E; Shacham S; Landesman Y; Daelemans D
    Oncotarget; 2016 Oct; 7(42):68842-68850. PubMed ID: 27634897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting Nuclear Exporter Protein XPO1/CRM1 in Gastric Cancer.
    Sexton R; Mahdi Z; Chaudhury R; Beydoun R; Aboukameel A; Khan HY; Baloglu E; Senapedis W; Landesman Y; Tesfaye A; Kim S; Philip PA; Azmi AS
    Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31569391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Supraphysiological nuclear export signals bind CRM1 independently of RanGTP and arrest at Nup358.
    Engelsma D; Bernad R; Calafat J; Fornerod M
    EMBO J; 2004 Sep; 23(18):3643-52. PubMed ID: 15329671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-catenin can bind directly to CRM1 independently of adenomatous polyposis coli, which affects its nuclear localization and LEF-1/beta-catenin-dependent gene expression.
    Ki H; Oh M; Chung SW; Kim K
    Cell Biol Int; 2008 Apr; 32(4):394-400. PubMed ID: 18262809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRM1-dependent, but not ARE-mediated, nuclear export of IFN-alpha1 mRNA.
    Kimura T; Hashimoto I; Nagase T; Fujisawa J
    J Cell Sci; 2004 May; 117(Pt 11):2259-70. PubMed ID: 15126627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear-cytoplasmic shuttling of APC regulates beta-catenin subcellular localization and turnover.
    Henderson BR
    Nat Cell Biol; 2000 Sep; 2(9):653-60. PubMed ID: 10980707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of multiple nuclear export sequences in Fanconi anemia group A protein that contribute to CRM1-dependent nuclear export.
    Ferrer M; Rodríguez JA; Spierings EA; de Winter JP; Giaccone G; Kruyt FA
    Hum Mol Genet; 2005 May; 14(10):1271-81. PubMed ID: 15790592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leptomycin B alters the subcellular distribution of CRM1 (Exportin 1).
    Rahmani K; Dean DA
    Biochem Biophys Res Commun; 2017 Jun; 488(2):253-258. PubMed ID: 28412356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topoisomerase II binds importin alpha isoforms and exportin/CRM1 but does not shuttle between the nucleus and cytoplasm in proliferating cells.
    Mirski SE; Sparks KE; Friedrich B; Köhler M; Mo YY; Beck WT; Cole SP
    Exp Cell Res; 2007 Feb; 313(3):627-37. PubMed ID: 17182034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Cellular Distribution of RanGAP1 Is Regulated by CRM1-Mediated Nuclear Export in Mammalian Cells.
    Cha K; Sen P; Raghunayakula S; Zhang XD
    PLoS One; 2015; 10(10):e0141309. PubMed ID: 26506250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.